Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by BIT Capital GmbH

BIT Capital GmbH lowered its stake in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 69.0% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,461 shares of the biotechnology company's stock after selling 9,923 shares during the quarter. BIT Capital GmbH's holdings in Axon Enterprise were worth $2,651,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of AXON. Asset Dedication LLC boosted its stake in Axon Enterprise by 11.3% during the fourth quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company's stock valued at $106,000 after buying an additional 18 shares during the last quarter. Bleakley Financial Group LLC lifted its stake in shares of Axon Enterprise by 1.3% in the 4th quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company's stock valued at $908,000 after purchasing an additional 20 shares during the last quarter. Venturi Wealth Management LLC boosted its holdings in shares of Axon Enterprise by 2.7% in the 4th quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company's stock worth $477,000 after purchasing an additional 21 shares during the period. Insigneo Advisory Services LLC increased its position in shares of Axon Enterprise by 1.4% during the 3rd quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company's stock valued at $627,000 after purchasing an additional 22 shares during the last quarter. Finally, Menard Financial Group LLC raised its holdings in Axon Enterprise by 0.8% during the 3rd quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company's stock valued at $1,204,000 after buying an additional 24 shares during the period. Hedge funds and other institutional investors own 79.08% of the company's stock.

Remove Ads

Axon Enterprise Stock Performance

NASDAQ AXON traded down $17.94 on Monday, hitting $517.01. 283,296 shares of the company's stock traded hands, compared to its average volume of 810,289. The firm has a market capitalization of $39.61 billion, a PE ratio of 133.59, a P/E/G ratio of 5.17 and a beta of 1.12. Axon Enterprise, Inc. has a 1-year low of $273.52 and a 1-year high of $715.99. The firm's 50-day moving average price is $589.62 and its two-hundred day moving average price is $550.61. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on AXON shares. Craig Hallum downgraded shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a research note on Monday, March 10th. Robert W. Baird increased their target price on Axon Enterprise from $600.00 to $800.00 and gave the stock an "outperform" rating in a research note on Friday, December 6th. TD Cowen initiated coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price target on the stock. The Goldman Sachs Group lifted their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a report on Monday, January 27th. Finally, Needham & Company LLC restated a "buy" rating and issued a $600.00 target price on shares of Axon Enterprise in a research note on Wednesday, February 26th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $604.67.

Insider Activity at Axon Enterprise

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm's stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the sale, the director now directly owns 6,929 shares in the company, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Jeri Williams sold 307 shares of the stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the transaction, the director now owns 1,627 shares in the company, valued at $899,275.44. This represents a 15.87 % decrease in their position. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.